
About Genome International India Private Limited
Data last updated:
Genome International India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the application development and software solutions segment of the technology and IT services sector. It was incorporated on 09 July 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U73100TN2004PTC053684. Its GSTIN is 33AAECG4502G2Z3 (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.02 Lakh. It was formerly known as Genome International Private Limited. It is led by directors Periannan Senapathy and Abarajeetha Rajendran.
Its last annual general meeting (AGM) was held on 29 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 383 I Cross Street Nehru Nagar Old Mahabalipuram Road Kottivakkam, Chennai, Tamil Nadu, India – 600096.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.08 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net loss of ₹11.72 Lakh (net margin -3.8%) and EBITDA of -₹4.51 Lakh (EBITDA margin -1.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Genome Life Sciences. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomels.com.
Company details
Name history
Genome International India has undergone 3 name changes throughout its history. The company was previously known as Genome International Private Limited, Genome International India Private Limited, and Genome Life Sciences Private Limited. The current legal name is Genome International India Private Limited.
| Company Name | Status |
|---|---|
| Genome International India Private Limited | Current |
| Genome International Private Limited | Previous |
| Genome Life Sciences Private Limited | Previous |
CIN history
Genome International India has one previous CIN (Corporate Identification Number): U72200TN2004PTC053684. The current CIN is U73100TN2004PTC053684, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TN2004PTC053684 | Current |
| U72200TN2004PTC053684 | Previous |
Contact details
Genome International India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is genomels.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address383 I Cross Street Nehru Nagar Old Mahabalipuram Road Kottivakkam, Chennai, Tamil Nadu, India – 600096
- IndustryInformation Technology, Application Development & Software Solutions
To see the full contact details of Genome International India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Genome International India operates one associated brand: Genome Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers comprehensive services for next-generation sequencing and big data analysis in life sciences. | genomels.com |
Business activity
The main business activity of Genome International India is information and communication. In detail, this covers publishing of computer operating systems, system software, application software, games, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J2 | Publishing of computer operating systems, system software, application software, games, etc. |
To see the full business activity and turnover split of Genome International India Private Limited, buy the company report.
Financials of Genome International India Private Limited
FY 2025 filings availableGenome International India Private Limited reported revenue of ₹3.08 Cr (down 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 200% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.5% | ||||
| Net Profit Margin | -3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genome International India Private Limited, buy the company report.
Board of directors of Genome International India Private Limited
Genome International India has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Periannan Senapathy Also directs: Velalar Mills Private Limited | Director | 09 Jul 2004 | 22 Years 3 Months | Current |
| Abarajeetha Rajendran Also directs: Velalar Mills Private Limited | Director | 09 Aug 2023 | 3 Years 2 Months | Current |
Auditor
Genome International India Private Limited is audited by S BALA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S BALA & CO | FY 2018 | 013958S |
Shareholding
The shareholding of Genome International India Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Genome International India Private Limited, buy the company report.
Legal cases
Genome International India Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Arbitration matter | Filed against the company by Ticel Bio Park Limited | Disposed |
| High Court, TAMIL NADU | Arbitration matter | Filed against the company by Ticel Bio Park Limited M/S.King and Patridge, Jose John- ,M.Narendran ,9884088148 | Disposed |
To see the full case history of Genome International India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genome International India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Genome International India Private Limited has a workforce of 30 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
GST
Genome International India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECG4502G2Z3 | Tamil Nadu | Active | 06 Jun 2018 |
To see the full GST registrations and return filing status of Genome International India Private Limited, buy the company report.
Recent activity
Genome International India Private Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Abarajeetha Rajendran ceased to be Additional Director on 22 Aug 2023.
Frequently asked questions
Genome International India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in application development and software solutions, within the information technology industry. It was incorporated on 09 July 2004 (22+ years old) and is registered under CIN U73100TN2004PTC053684.
Genome International India has 2 current directors:
- Periannan Senapathy - Director
- Abarajeetha Rajendran - Director
The latest financial statements of Genome International India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 December 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Genome International India is 33AAECG4502G2Z3, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Genome International India is U73100TN2004PTC053684. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genome International India has 3 court cases on record: 3 filed against it.
Genome International India was incorporated on 09 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chennai.
Abarajeetha Rajendran ceased to be Additional Director on 22 Aug 2023. Nathambal ceased to be Director on 11 Aug 2023. Abarajeetha Rajendran was appointed as Director on 09 Aug 2023. Genome International India has 7 board changes on record in total.
Genome International India can be reached through the website genomels.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Genome International India is at 383 I Cross Street Nehru Nagar Old Mahabalipuram Road Kottivakkam, Chennai, Tamil Nadu, India – 600096.